11 TH INTERNATIONAL CONFERENCE OF CONTEMPORARY ONCOLOGY

 

POZNAN, 13.03.2019 - 15.03.2019

13
March
Wednesday
Room 1
12:00 - 13:40
SESSION 1. BIOMARKERS
Chair:
Theresa WHITESIDE, University of Pittsburgh Cancer Institute, PA, USA
Magdalena CHECHLIŃSKA, Maria Skłodowska-Curie Institute – Oncology Center, Warsaw, PL
12:00 - 12:25
Markers of progression risk in patients with squamous cell vulvar carcinoma
Magdalena KOWALEWSKA, Maria Skłodowska-Curie Institute – Oncology Center, Warsaw, PL
12:25 - 12:50
Molecular characteristics of Burkitt-like lymphoma with 11q aberration: Meeting the classification and diagnostic challenges
Magdalena CHECHLIŃSKA, Maria Skłodowska-Curie Institute – Oncology Center, Warsaw, PL
12:50 - 13:15
Melanoma-derived exosomes in plasma of melanoma patients: biomarkers of tumor progression?
Theresa WHITESIDE, University of Pittsburgh Cancer Institute, PA, USA
13:15 - 13:40
Human germ cell tumors – news and views
Leendert H. LOOIJENGA, Erasmus MC-University Medical Center Rotterdam, Rotterdam and Cancer Institute and Princess Maxima Center for Paediatric Oncology, Utrecht, NLD
13:40 - 14:20
LUNCH
14:20 - 16:25
SESSION 2. NOVEL IMMUNOTHERAPY APPROACHES I
Chair:
Dominika NOWIS, Warsaw Medical University, Warsaw, PL
Magdalena Tary-Lehmann, C.TL, CWRU Cleveland, OH, USA
14:20 - 14:45
The role of arginase-1 in antitumor immune response
Dominika NOWIS, Warsaw Medical University, Warsaw, PL
14:45 - 15:10
Studies of specific T cell immunity against tumors at single cell resolution
Magdalena Tary-Lehmann, C.TL, CWRU Cleveland, OH, USA
15:10 - 15:35
Pre-spliced mRNAs as a source for generating antigenic peptides for the MHC class I pathway
Robin FAHRAEUS, Edinburgh, UK; Gdansk, PL
15:35 - 16:00
Old cancer vaccines – new mechanisms and perspectives
Andrzej MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL
16:00 - 16:20
COFFEE BREAK
16:20 - 18:55
SESSION 3. NOVEL CANCER THERAPEUTIC APPROACHES II
Chair:
Paweł KALINSKI, Roswelt Park Memorial Institute, Buffalo, NY, USA
Theodore HUPP, Edinburg, UK, Gdansk, PL
16:20 - 16:45
Mass Spectrometry Imaging - new approach in molecular imaging of cancer
Piotr WIDŁAK, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Gliwice, PL
16:45 - 17:10
Hypoxia normalization: the role of PTEN in tuning the microenvironment
Claudine KIEDA, Orleans, France; Warsaw, PL
17:10 - 17:35
Developing therapeutic strategies for the treatment of esophageal adenocarcinoma
Theodore HUPP, Edinburgh, UK, Gdansk, PL
17:35 - 18:00
The management of the HPV positive head nad neck cancer in the face of new evidence
Paweł GOLUSINSKI, University of Zielona Góra, PL
18:00 - 18:25
SELL120-first-in-class CDK8 inhibitor as new therapeutic option for leukemia and lymphoma
Tomasz RZYMSKI, Selvita, Cracow, PL
18:25 - 19:15
OPENING CEREMONY AND WELCOME ADDRESS
Welcome address:
Andrzej MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL

Keynote lecture:
The Multidimensional Nature of Cancer Classification: Consequences for Molecular Pathology
Ian A. CREE, International Agency for Research on Cancer, WHO, Lyon, FR
19:15 - 20:30
POSTER SESSION
19:15
DINNER
14
March
Thursday
Room 1
09:00 - 12:40
SESSION 4. HEMATOLOGY
Chair:
Lidia GIL, Poznan University of Medical Sciences, Poznan, PL
Sebastian GIEBEL, Gliwice, PL
09:00 - 09:25
Are we ready for targeted therapy in AML
Lidia GIL, Poznan University of Medical Sciences, Poznan, PL
09:25 - 09:50
Immunotherapy of acute lymphoblastic leukemia
Sebastian GIEBEL, Gliwice, PL
09:50 - 10:15
Risk stratification and treatment decisions in Philadelphia-negative myeloproliferative neoplasms
Krzysztof LEWANDOWSKI, Poznan University of Medical Sciences, Poznan, PL
10:15 - 10:40
Beyond the horizon: new treatment strategies for multiple myeloma
Dominik DYTFELD, Poznan University of Medical Sciences, Poznan, PL
10:40 - 11:00
COFFEE BREAK
11:00 - 11:25
Targeted and immunotherapy in implimia mutually supported
Andrzej LANGE, Hirszfeld Inst Imm Exp Ther, Lower Silesian Center for Cellular Transplantation & National Bone Marrow Donor Registry, Wroclaw, PL
11:25 - 11:50
Targeting Carbohydrate Metabolism for Cancer Treatment
Waldemar PRIEBE, MD Anderson Cancer Center, Houston, TX, USA
11:50 - 12:15
Personalized medicine-guided synthetic lethality eliminates leukemia stem cells
Tomasz SKÓRSKI, Temple University, Philadelphia, USA
12:15 - 12:40
Impaired proteodynamics in hematological and other malignancies; potential biomarkers and therapeutic targets
Jacek WITKOWSKI, GUM, Gdansk, PL
12:40
SESSION 5. BREAST CANCER
Chair:
Tadeusz PIEŃKOWSKI, Clinical Department of Oncology and Hematology, Central Clinical Hospital of the MSWiA, Warsaw, PL
Jan LUBINSKI, Pomeranian Medical University, Szczecin, PL
12:40 - 13:05
Neoadjuvant treatment of breast cancer
Elżbieta SENKUS, GUM, Gdansk, PL
13:05 - 14:05
LUNCH
14:05 - 14:30
Targeted treatment of breast cancer
Tadeusz PIEŃKOWSKI, Clinical Department of Oncology and Hematology, Central Clinical Hospital of the MSWiA, Warsaw, PL
14:30 - 14:55
Nonpalpable lesions in breast cancer - new methods of visualization in breast conserving surgery
Dawid MURAWA, Department of Surgery and Oncology, University of Zielona Góra, PL
14:55 - 15:20
Platins in the treatment of BRCA1 dependent breast cancers
Jan LUBINSKI, Pomeranian Medical University, Szczecin, PL
15:20 - 15:45
The role of sphingolipid metabolism in multidrug resistance of breast cancer cells
Maciej UGORSKI, Wrocław University of Environmental and Life Sciences,Wrocław, PL
15:45 - 16:10
SPECIAL LECTURE
Beyond hazard ratio: measures of treatment effect on survival
Tomasz BURZYKOWSKI, Hasselt University, BEL
16:10 - 17:25
SESSION 6. CANCER CELL BIOLOGY
Chair:
Pravin SEHGAL, New York Medical College, NY, USA
Bożena KAMINSKA-KACZMAREK, Nencki Institute of Experimental Biology, Warsaw, PL
16:10 - 16:35
Phase-separated biomolecular condensates in cancer cell biology: the MxA and STAT3 stories
Pravin SEHGAL, New York Medical College, NY, USA
16:35 - 17:00
How to sensitize glioblastoma cells to chemotherapeutics?
Bożena KAMINSKA-KACZMAREK, Nencki Institute of Experimental Biology, Warsaw, PL
17:00 - 17:25
Senescent peritoneal mesothelium promotes the progression of ovarian cancer
Krzysztof KSIĄŻEK, Poznan University of Medical Sciences, Poznan, PL
17:25 - 17:50
Some chemotherapeuthics treated cancer cells display a specific phenotype being a combination of stem - like and senescent cell features
Halina WAŚ, WIM, Warsaw, PL
17:50 - 19:05
SESSION 7. T CELL DYSFUNCTION AND CANCER IMMUNOTHERAPY
Chair:
Salem CHOUAIB, Thumbay Research Institute, GMU Ajman-UAE and Gustave Roussy, Villejuif, FR
17:50 - 18:15
Introduction
Salem CHOUAIB, Thumbay Research Institute, GMU Ajman-UAE and Gustave Roussy-Villejuif, FR
18:15 - 18:40
CAR T-cells: life in the fast-lane
Benjamin DRAPER, Bermondsey Wing, Guy's Hospital, London, UK
18:40 - 19:05
Engineering of therapeutic T cells
Hans STAUSS, UCL, London, UK
19:05 - 19:55
CLINICAL SESSION 8: KIDNEY CANCER
Chair:
Bożena CYBULSKA-STOPA
Cezary SZCZYLIK
19:05 - 19:30
Immunotherapy in renal cell carcinoma
Bożena CYBULSKA-STOPA
19:30 - 19:55
Sponsored lecture
Targeted therapy of advanced renal cell carcinoma
Cezary SZCZYLIK
19:55 - 20:20
Sponsored lecture
Personalizing treatment of kidney cancer (renal cell carcinoma) based on the current opportunities and new strategies
Rafał STEC
20:30
Dinner for lecturers
15
March
Friday
Room 1
09:00 - 10:40
CLINICAL SESSION 9: MELANOMA
Chair:
Andrzej MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL
Piotr RUTKOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
09:00 - 09:25
Patroned by MSD
Periopertive therapy of melanoma
Piotr RUTKOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
09:25 - 09:50
Adjuvant therapy of melanoma
Jacek MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL
09:50 - 10:15
Status of targeted therapy in the treatment of advanced melanoma
Anna CZARNECKA, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
10:15 - 10:40
Can we cure advanced melanoma
Marek ZIOBRO, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, PL
10:40 - 11:00
COFFEE BREAK
11:00 - 12:15
CLINICAL SESSION 10: LUNG CANCER
Chair:
Adam SZPECHCIŃSKI, National Institute of Tuberculosis and Lung Diseases, Warsaw, PL
Katarzyna STENCEL, Poznan University of Medical Sciences, Poznan, PL
11:00 - 11:25
Genetic and epigenetic markers of non-small cell lung cancer in peripheral blood: an update
Adam SZPECHCIŃSKI, National Institute of Tuberculosis and Lung Diseases, Warsaw, PL
11:25 - 11:50
Patroned by MSD
Place of immunotherapy in the treatment of NCSLC
Maciej BRYL, Poznan University of Medical Sciences, Poznan, PL
11:50 - 12:15
Personalized targeted therapy of NCSLC
Katarzyna STENCEL, Poznan University of Medical Sciences, Poznan, PL
12:15 - 13:00
LUNCH
13:00 - 14:40
CLINICAL SESSION 11: COLORECTAL CANCER
Chair:
Marek WOJTUKIEWICZ, Bialystok Medical University, Bialystok, PL
Andrzej DEPTAŁA, Clinical Department of Oncology and Hematology, Central Clinical Hospital of the MSWiA, Warsaw, PL
13:00 - 13:25
Molecular classification of colorectal cancer
Andrzej DEPTAŁA, Clinical Department of Oncology and Hematology, Central Clinical Hospital of the MSWiA, Warsaw, PL
13:25 - 13:50
Sponsored lecture
Choice of strategy in mCRC treatment based on guidelines and clinical practice
Marek WOJTUKIEWICZ, Bialystok Medical University, Bialystok, PL
13:50 - 14:15
Nonoperative management of rectal cancer: are we there yet?
Piotr MARTENKA, Greater Poland Cancer Centre, Poznan, PL
14:15 - 14:40
Immunotherapy of colorectal cancer
Dariusz IZYCKI, Poznan University of Medical Sciences, Poznan, PL
14:40 - 15:30
CLINICAL SESSION 12: PROSTATE CANCER
Chair:
Piotr MILECKI, Greater Poland Cancer Centre, Poznan, PL
Paweł WIECHNO, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
14:40 - 15:05
Sponsored lecture
Bones – a critical organ in the treatment of prostate cancer
Paweł WIECHNO, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
15:05 - 15:30
Local therapy (SBRT) in metastatic prostate cancer in 2019
Piotr MILECKI, Greater Poland Cancer Centre, Poznan, PL
15:30
SESSION 13: ADVANCES IN CLINICAL GENETICS OF CANCERS
Chair:
Jan LUBIŃSKI, Pomeranian Medical University, Szczecin, PL
Anna JAKUBOWSKA, Pomeranian Medical University, Szczecin, PL
15:30 - 15:55
Search for new genomic changes associated with high risk of cancer
Cezary CYBULSKI, Pomeranian Medical University, Szczecin, PL
15:55 - 16:20
Biological role of DNA methylation and its implication in medicine - association of constitutional BRCA1 gene promoter methylation with breast cancer risk
Anna JAKUBOWSKA, Pomeranian Medical University, Szczecin, PL
16:20 - 16:45
Rules for medical management of patients with BRCA1 gene mutation
Jacek GRONWALD, Pomeranian Medical University, Szczecin, PL
16:45 - 17:10
Micro- and macronutrients as markers of cancer prognosis and prevention
Jan LUBIŃSKI, Pomeranian Medical University, Szczecin, PL
17:10 - 17:20
COFFEE BREAK
17:20 - 18:20
SESSION 14: ORAL PRESENTATIONS SELECTED FROM ABSTRACTS
17:20 - 17:30
Administration of intraoperative radiotherapy reduces the ability of surgical wound fluids collected from breast cancer patients to induce migration of cancer cells
Igor Piotrowski, Katarzyna Kulcenty, Karolina Zaleska, Mateusz Wichtowski, Joanna Wróblewska, Dawid Murawa, Wiktoria Suchorska
17:30 - 17:40
Expression of mucins in hepatocellular carcinoma
Aldona Kasprzak, Joanna Surdyk-Zasada, Małgorzata Andrzejewska
17:40 - 17:50
Recurrent loss of ELF1 in classical Hodgkin lymphoma
Julia Paczkowska, Natalia Soloch, Magdalena Bodnar, Katarzyna Kiwerska, Joanna Janiszewska, Julia Vogt, Elżbieta Domanowska, Jose Ignacio Martin-Subero, Ole Ammerpohl, Wolfram Klapper, Andrzej Marszałek, Reiner Siebert, Maciej Giefing
17:50 - 18:00
Novel mechanism of metastasis regulated by SNAIL transcription factor in mesenchymal tumors
Klaudia Skrzypek, Artur Nieszporek, Anna Kusienicka, Małgorzata Lasota, Paweł Konieczny, Marcin Majka
18:00 - 18:10
Epigenetically mediated CEACAM6 downregulation in laryngeal squamous cell carcinoma is correlated with tumor stage
Kinga Bednarek, Magdalena Kostrzewska-Poczekaj, Marcin Szaumkessel, Katarzyna Kiwerska, Julia Paczkowska, Ewa Byzia, Adam Ustaszewski, Joanna Janiszewska, Anna Bartochowska, Reidar Grenman, Malgorzata Wierzbicka, Krzysztof Szyfter, Maciej Giefing
18:10
CLOSING CEREMONY
Best Poster Competition Awards